17 November 2022 in Journal of General Physiology
Muscle contraction is controlled at two levels: the thin and the thick filaments. The latter level of control involves three states of myosin heads: active, disordered relaxed (DRX), and super-relaxed (SRX), the distribution of which controls the number of myosins available to interact with actin. How these are controlled is still uncertain. Using fluorescently labeled ATP, we were able to spatially assign the activity of individual myosins within the sarcomere. We observed that SRX comprises 53% of all heads in the C-zone compared with 35% and 44% in the P- and D-zones, respectively. The recently FDA-approved hypertrophic cardiomyopathy drug, mavacamten (mava), significantly decreased DRX, favoring SRX in both the C- and D-zones at 60% and 63%, respectively. Since thick filament regulation is in part regulated by the myosin-binding protein-C (MyBP-C), we also studied PKA phosphorylation. This had the opposite effect as mava, specifically in the C-zone where it decreased SRX to 34%, favoring DRX. These results directly show that excess concentrations of mava do increase SRX, but the effect is limited across the sarcomere, suggesting mava is less effective on skeletal muscle. In addition, we show that PKA directly affects the contractile machinery of skeletal muscle leading to the liberation of repressed heads. Since the effect is focused on the C-zone, this suggests it is likely through MyBP-C phosphorylation, although our data suggest that a further reserve of myosins remain that are not accessible to PKA treatment.
7 August 2025 in Molecular and Cellular Endocrinology
The androgen receptor (AR) plays a pivotal role in male physiological development and is implicated in the pathogenesis of various diseases, including prostate cancer. Its N-terminal domain (NTD), characterized by intrinsic disorder, is essential for transcriptional activation. Despite its importance, the precise mechanisms by which the NTD regulates AR's DNA-binding activity remain incompletely understood. This research elucidates the allosteric control mediated by specific NTD subregions-the N-terminal region (NR) and the C-terminal region (CR)-over the DNA binding properties of a truncated AR construct comprising the DNA-binding and ligand-binding domains (ΔNTD-AR). Microscale Thermophoresis (MST) and single-molecule fluorescence imaging were employed to investigate these interactions. This study demonstrates that the NTD subregions exert differential modulatory effects on the kinetics and affinity of ΔNTD-AR binding to DNA. MST analyses indicated that CR reduces ΔNTD-AR DNA binding affinity concentration-dependently, whereas NR did not significantly alter affinity. Single-molecule investigations revealed NR accelerates dissociation, while CR markedly diminishes binding frequency and accelerates dissociation. Combined NR and CR exerted complex effects, synergistically reducing affinity at high concentrations and altering kinetics distinctively compared to individual subregions. Collectively, these results delineate distinct functional roles for the NR and CR subregions in allosterically modulating AR-DNA interactions. This detailed understanding of intrinsic AR regulation offers mechanistic insights into receptor function and highlights potential allosteric sites for therapeutic intervention.
15 May 2025 in Protein Science
Spinal bulbar muscular atrophy (SBMA) is caused by a polyglutamine expansion (pQe) in the N‐terminal transactivation domain of the human androgen receptor (AR‐NTD), resulting in a combination of toxic gain‐ and loss‐of‐function mechanisms. The structural basis of these processes has not been resolved due to the disordered nature of the NTD, which hinders experimental analyses of its detailed conformations. Here, using extensive computational modeling, we show that AR‐NTD forms dynamic compact regions, which upon pQe re‐organize dynamically, mediated partly by direct pQ interaction with the Androgen N‐Terminal Signature (ANTS) motif. The altered dynamics of the NTD result in a perturbation of interdomain interactions, with potential implications for the binding of the receptor protein to its response element. Oligomeric aggregation of the dynamic misfolded NTD exposes pQe, but blocks tau‐5 and the FQNLF motif, which could lead to aberrant receptor transcriptional activity. These observations suggest a structural mechanism for AR dysfunction in SBMA.
18 March 2026 in Biochemical Journal
Nuclear receptors (NRs) comprise a superfamily of (ligand-)regulated transcription factors that are pivotal in orchestrating gene networks essential for development, metabolism, and cellular homeostasis. Their activity is critical for normal physiology, and consequently, dysregulation of NR signalling is implicated in a wide array of human diseases. Within this superfamily, the orphan nuclear receptor Nur77 and the glucocorticoid receptor (GR) are key regulators that exhibit significant cross-talk, primarily antagonistic, which is crucial for modulating inflammatory and stress responses. Despite the recognised importance of their interplay, the precise molecular mechanisms by which GR modulates Nur77’s engagement with DNA remain incompletely defined. The present study elucidates the direct impact of GR and its ligand, dexamethasone (Dex), on the DNA binding dynamics of Nur77. Single-molecule DNA tightrope assays revealed that Nur77 employs a three-dimensional diffusion-based search mechanism on non-specific DNA, characterised by transient interactions with two distinct dissociation kinetic profiles. GR significantly stabilises Nur77–DNA interactions, evidenced by a shift towards longer residence times, primarily achieved by slowing the dissociation of the more transiently interacting Nur77 population. Conversely, single-molecule analysis and biochemical assays demonstrated that Dex alone markedly reduces Nur77’s overall DNA binding affinity kinetics and frequency in a sequence-dependent manner, to such an extent that accurate quantification was unfeasible. These findings delineate distinct modulatory effects of the GR protein and its ligand on Nur77–DNA interactions, providing crucial biophysical insights into their complex regulatory interplay and revealing a direct, GR-independent impact of Dex on Nur77’s DNA engagement.